NOW

"REVIEWS OF INFECTIOUS DISEASES"- the former journal of IDSA, publishes that the treatment endpoint of Lyme is UNKNOWN

It is an absolute fact, that since this report was published in 1989, [the year before the American Lyme Disease Foundation http://www.aldf.com (simultaneously, the EUCALB, by Allen Steere) was founded by John Connolly http://www.castleconnolly.com , who used to be the something on the order of the Hospital Administrator of Valhalla (New York Medical College, which used to be a Catholic Medical School, but now has Kaiser writing General Practitioner Training Protocol, probably thanks to that Disgrace-to-the- Race, John Connolly),]... that we have not progressed past this 1989 report, on the treatment of Lyme disease.

Klempner's study was not a study of the effects of long term treatment of Lyme disease, because some of the patients had never had IV ceftriaxone before and Klempner never revealed which primers he used to assess the patients' spinal fluid. Klempner used CDC criteria for "Lyme disease" (which is Steere's LymeRIX arthritis Disease and is entirely bogus), for the seropositives, and he used the Lyme/MS patients ( see: http://www.geocities.com/kmdickson0308/1-6.txt Steere: Lyme is like Neurosyphilis, Rheumatoid arthritis and Multiple Sclerosis) and Klempner did that report that HLA-DQB1*0602 data (demonstrating Lyme is a STRONG candidate for a cause of Multiple Sclerosis). Klempner stopped the "study" before it was completed, the numbers had no data strength, and probably he used bogus primers... (who knows, since Steere appears to own Imugen with Molloy, and Steere and Berardi brought back a German strain to test USA patients, perhaps Klempner used primers from Borreliae periwinklii which infects only snails, for all we know)... See http://www.ilads.org

...with the exception of what Brian Fallon is doing at Columbia. http://www.columbia-lyme.org

THIS MEANS, (the following report), THE TREATMENT OF LYME DISEASE REMAINS AN UNKNOWN.